Research map: Neoadjuvant Chemotherapy Versus Upfront Surgery for cT2N1 or cT3a ‐ bN0 ‐1 Middle‐High Rectal Cancer
Back to the article
Papers in this map
- Preoperative Versus Postoperative Chemoradiotherapy for Locally Advanced Rectal Cancer: Results of the German CAO/ARO/AIO-94 Randomized Phase III Trial After a Median Follow-Up of 11 Years · Rolf Sauer · 2012 · 2153 citations · Cited by this paper
- Helicobacter pylori Infection and the Risk of Biliary Tract and Pancreatic Cancers: Subsite‐Specific Associations in a Japanese Population · 2026 · Related
- Rectal Cancer · Richard J. Heald · 1998 · 1405 citations · Cited by this paper
- Sodium‐Glucose Cotransporter 2 Inhibitors and Cancer Risk in Patients With Type 2 Diabetes Mellitus: An Active Comparator, New‐User Cohort Study · 2026 · Related
- Preoperative High-resolution Magnetic Resonance Imaging Can Identify Good Prognosis Stage I, II, and III Rectal Cancer Best Managed by Surgery Alone · Fiona G. M. Taylor · 2011 · 662 citations · Cited by this paper
- Unraveling the Plasma Extracellular Vesicles Proteome: Predictors of Resistance in Immunotherapy of Advanced Melanoma · 2026 · Related
- Preoperative Magnetic Resonance Imaging Assessment of Circumferential Resection Margin Predicts Disease-Free Survival and Local Recurrence: 5-Year Follow-Up Results of the MERCURY Study · Fiona G.M. Taylor · 2013 · 652 citations · Cited by this paper
- The Optimal Lung Cancer Ct Screening Strategy: A Cost‐Effectiveness Study Incorporating Nelson Evidence, Evolving Cost of Treatment and Smoking Cessation Interventions · 2026 · Related
- Preoperative Treatment of Locally Advanced Rectal Cancer · Deborah Schrag · 2023 · 493 citations · Cited by this paper
- The Circulating Cholangiocarcinoma Protein Biomarkers CRP and MASP2 Also Predict Gallbladder Cancer Risk · 2026 · Related
- Preoperative Chemotherapy for Operable Colon Cancer: Mature Results of an International Randomized Controlled Trial · Dion G. Morton · 2023 · 480 citations · Cited by this paper
- Obesity‐Driven Early‐Onset Colorectal Cancer: Mechanistic Insights and Emerging Clinical Implications · 2026 · Related
- Tumor Regression Grading After Preoperative Chemoradiotherapy for Locally Advanced Rectal Carcinoma Revisited: Updated Results of the CAO/ARO/AIO-94 Trial · Emmanouil Fokas · 2014 · 464 citations · Cited by this paper
- Changing the History of Science—An Editorial Perspective on Critical Developments in Current Citation Practice, “Forgetting” the Pioneers of Scientific Discoveries · 2026 · Related
- Long-Term Results of Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy: The Randomized Phase II OPRA Trial · Floris S. Verheij · 2023 · 382 citations · Cited by this paper
- Targeted Therapy and Oral Chemotherapy as Maintenance Treatment in Pediatric Very‐High‐Risk and High‐Risk Rhabdomyosarcoma: A Retrospective Study of Efficacy and Safety · 2026 · Related
- NCCN Guidelines® Insights: Rectal Cancer, Version 3.2024 · Al B. Benson · 2024 · 273 citations · Cited by this paper
- HPV Serology and Circulating Viral DNA for Detection, Genotyping, and Measurement of Disease Burden in Oropharyngeal Cancer · 2026 · Related
- Localised rectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up · Ralf‐Dieter Hofheinz · 2025 · 192 citations · Cited by this paper
- Future Trends in Cancer Prevention and Interception in Cancer Predisposition Syndromes: Leveraging Insights From High‐Risk Populations · 2026 · Related
- Oncological outcome after MRI-based selection for neoadjuvant chemoradiotherapy in the OCUM Rectal Cancer Trial · the OCUM group · 2018 · 111 citations · Cited by this paper
- Neoadjuvant Chemotherapy With CAPOX Versus Chemoradiation for Locally Advanced Rectal Cancer With Uninvolved Mesorectal Fascia (CONVERT): Initial Results of a Phase III Trial · Wei-Jian Mei · 2022 · 87 citations · Cited by this paper
- Risk-Adapted Neoadjuvant Chemoradiotherapy in Rectal Cancer: Final Report of the OCUM Study · Reinhard Ruppert · 2023 · 84 citations · Cited by this paper
- The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of colorectal cancer, 2024 update · Feng Wang · 2024 · 79 citations · Cited by this paper
- Neoadjuvant Radiotherapy Versus Surgery Alone for Stage II/III Mid-low Rectal Cancer With or Without High-risk Factors · Xiangbing Deng · 2019 · 58 citations · Cited by this paper
- Chemoradiotherapy and Local Excision vs Total Mesorectal Excision in T2-T3ab, N0, M0 Rectal Cancer · Xavier Serra‐Aracil · 2025 · 29 citations · Cited by this paper
- Early response to upfront neoadjuvant chemotherapy (CAPOX) alone in low- and intermediate-risk rectal cancer: a single-arm phase II trial · Xiangbing Deng · 2021 · 27 citations · Cited by this paper
- MRI‐defined T3, clear mesorectal fascia mid–low rectal cancer: is neoadjuvant treatment necessary? · Ziwei Zeng · 2024 · 9 citations · Cited by this paper
- A Significant Proportion of Stage II and III Rectal Cancers, Selected by Precision Magnetic Resonance, Can Safely Be Managed by Upfront Total Mesorectal Excision Surgery Without Neoadjuvant Therapy · Laura Melina Fernandez · 2025 · 5 citations · Cited by this paper
- Untitled · Cited by this paper
Source: OpenAlex (CC0)